Skip to main content

Advertisement

SpringerLink
Log in

Robotic surgery and limitations

  • Letter
  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Maeso S, Reza M, Mayol JA, Blasco JA, Guerra M, Andradas E, Plana MN (2010) Efficacy of the Da Vinci surgical system in abdominal surgery compared with that of laparoscopy: a systematic review and meta-analysis. Ann Surg 252(2):254–262

    Article  PubMed  Google Scholar 

  2. Barbash GI, Glied SA (2010) New technology and health care costs—the case of robot-assisted surgery. N Engl J Med 363(8):701–704

    Article  PubMed  CAS  Google Scholar 

  3. Scozzari G, Rebecchi F, Millo P, Rocchietto S, Allieta R, Morino M (2011) Robot-assisted gastrojejunal anastomosis does not improve the results of the laparoscopic Roux-en-Y gastric bypass. Surg Endosc 25(2):597–603

    Article  PubMed  Google Scholar 

  4. Ziogas D, Polychronidis A, Kanellos I, Roukos D (2009) Laparoscopic colectomy survival benefit for colon cancer: is evidence from a randomized trial true? Ann Surg 249(4):695–696

    Article  PubMed  Google Scholar 

  5. Katsios GC, Baltogiannis G, Roukos DH (2010) Laparoscopic surgery for gastric cancer: comparative-effectiveness research and future trends. Expert Rev Anticancer Ther 10(4):473–476

    Article  PubMed  Google Scholar 

  6. Liakakos T, Roukos D (2008) Laparoscopic gastrectomy: advances enable wide clinical application. Surg Endosc 22(6):1553–1555

    Article  PubMed  CAS  Google Scholar 

  7. Liakakos T, Roukos DH (2009) Randomized evidence for laparoscopic gastrectomy short-term quality of life improvement and challenges for improving long-term outcomes. Ann Surg 250(2):349–350

    Article  PubMed  Google Scholar 

  8. Roukos DH (2009) Laparoscopic gastrectomy and personal genomics: high-volume surgeons and predictive biomedicine may govern the future for resectable gastric cancer. Ann Surg 250:650–651

    Article  PubMed  Google Scholar 

  9. Liakakos T, Roukos DH (2008) Is there any long-term benefit in quality of life after laparoscopy-assisted distal gastrectomy for gastric cancer? Surg Endosc 22(5):1402–1404

    Article  PubMed  Google Scholar 

  10. Ziogas D, Roukos D (2008) Robotic surgery for rectal cancer: May it improve also survival? Surg Endosc 22(5):1405–1406

    Article  PubMed  Google Scholar 

  11. Roukos DH (2011) Cancer genome explosion and systems biology: Impact on surgical oncology? Ann Surg Oncol 18(1):12–15

    Article  PubMed  Google Scholar 

  12. Roukos DH (2010) Next-generation sequencing and epigenome technologies: potential medical applications. Expert Rev Med Devices 7(6):723–726

    Article  PubMed  CAS  Google Scholar 

  13. Roukos DH (2010) Complete genome sequencing and network modeling to overcome trastuzumab resistance. Pharmacogenomics 11(8):1039–1043

    Article  PubMed  CAS  Google Scholar 

  14. Roukos DH (2010) Next-generation, genome sequencing-based biomarkers: concerns and challenges for medical practice. Biomark Med 4(4):583–586

    Article  PubMed  Google Scholar 

  15. Roukos DH, Tzakos A, Zografos G (2009) Current concerns and challenges towards tailored anti-angiogenic therapy in cancer. Expert Rev Anticancer Ther 9(10):1413–1416

    Article  PubMed  Google Scholar 

  16. Roukos DH (2009) Breast cancer outcomes: the crucial role of the breast surgeon in the era of personal genetics and systems biology. Ann Surg 249(6):1067–1068

    Article  PubMed  Google Scholar 

  17. Roukos DH (2010) Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management? Expert Rev Mol Diagn 10(3):247–250

    Article  PubMed  Google Scholar 

  18. Ziogas D, Roukos DH (2009) CDH1 testing: Can it predict the prophylactic or therapeutic nature of total gastrectomy in hereditary diffuse gastric cancer? Ann Surg Oncol 16(10):2678–2681

    Article  PubMed  Google Scholar 

  19. Katsios C, Roukos DH (2010) Individual genomes and personalized medicine: life diversity and complexity. Per Med 7(4):347–350

    Article  CAS  Google Scholar 

  20. Roukos DH, Katsios C, Liakakos T (2010) Genotype-phenotype map and molecular networks: a promising solution in overcoming colorectal cancer resistance to targeted treatment. Expert Rev Mol Diagn 10(5):541–545

    Article  PubMed  CAS  Google Scholar 

  21. Roukos DH, Kappas AM, Tsianos E (2002) Role of surgery in the prophylaxis of hereditary cancer syndromes. Ann Surg Oncol 9(7):607–609

    Article  PubMed  Google Scholar 

  22. Roukos DH, Agnanti NJ, Paraskevaidis E, Kappas AM (2002) Approaching the dilemma between prophylactic bilateral mastectomy or oophorectomy for breast and ovarian cancer prevention in carriers of BRCA1 or BRCA2 mutations. Ann Surg Oncol 9(10):941–943

    PubMed  Google Scholar 

  23. Roukos DH (2009) Isolated tumor cells in breast cancer. N Engl J Med 361:1994–1995; author reply 1995–1996

    Google Scholar 

  24. Roukos DH, Ziogas D (2010) From tumor size and HER2 status to systems oncology for very early breast cancer treatment. Expert Rev Anticancer Ther 10(2):123–128

    Article  PubMed  CAS  Google Scholar 

  25. Roukos DH, Kappas AM (2002) Targeting the optimal extent of lymph node dissection for gastric cancer. J Surg Oncol 81:59–62

    Article  PubMed  Google Scholar 

  26. Kappas AM, Fatouros M, Roukos DH (2004) Is it time to change surgical strategy for gastric cancer in the United States? Ann Surg Oncol 11:727–730

    Article  PubMed  Google Scholar 

  27. Roukos DH (1998) Extended lymphadenectomy in gastric cancer: when, for whom and why. Ann R Coll Surg Engl 80(1):16–24

    PubMed  CAS  Google Scholar 

  28. Roukos DH (2000) Extended (D2) lymph node dissection for gastric cancer: do patients benefit? Ann Surg Oncol 7:253–255

    Article  PubMed  CAS  Google Scholar 

  29. Roukos DH, Kappas AM, Agnantis NJ (2003) Perspectives and risks of breast-conservation therapy for breast cancer. Ann Surg Oncol 10:718–721

    Article  PubMed  Google Scholar 

  30. Briasoulis E, Fatouros M, Roukos DH (2007) Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use? Ann Surg Oncol 14:2691–2695

    Article  PubMed  Google Scholar 

  31. Roukos DH (2011) Measurable evidence of miRNAs as regulators of cancer networks and therapeutic targets. Expert Rev Med Devices 8(2):123–126

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosure

C. Hottenrott has no conflicts of interest or financial ties to disclose.

Author information

Authors and Affiliations

  1. Chirurgische Klinik, St. Elisabethenkrankenhaus, Ginnheimer Straße 3, 60487, Frankfurt am Main, Germany

    Christof Hottenrott

Authors
  1. Christof Hottenrott
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christof Hottenrott.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hottenrott, C. Robotic surgery and limitations. Surg Endosc 26, 580–581 (2012). https://doi.org/10.1007/s00464-011-1894-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-011-1894-8

Keywords

Search

Navigation